Chimeric Element-Regulated MRI Reporter System for Mediation of Glioma Theranostics

Area of Science:

• Biotechnology
• Molecular Biology
• Oncology

Background:

• Glioblastoma presents a significant therapeutic challenge with a poor prognosis.
• Reporter-based MRI shows promise for tumor visualization but requires robust reporter gene expression.
• Existing reporter systems have limitations in enhancing expression for effective glioma detection and therapy.

Purpose of the Study:

• To develop a chimeric element-regulated ferritin heavy chain 1 (FTH1) reporter system.
• To enhance MRI-based glioma detection through improved reporter gene expression.
• To enable targeted therapy via transferrin receptor (TfR)-mediated drug delivery.

Main Methods:

• Constructed a chimeric FTH1 expression system using a tumor-specific PEG3 promoter, bFGF-2 5'UTR, and WPRE.
• Delivered constructs via lentiviral vectors to glioblastoma cells and xenografts.
• Assessed FTH1/TfR expression, iron accumulation, MRI signal changes, and in vitro/in vivo therapeutic efficacy of transferrin-modified doxorubicin liposomes (Tf-LPD).

Main Results:

• The chimeric system significantly increased FTH1 expression and TfR upregulation compared to controls.
• Enhanced iron accumulation led to reduced T2 relaxation times, improving MR contrast.
• Tf-LPD demonstrated TfR-dependent uptake, induced apoptosis, and markedly reduced tumor growth in vivo.

Conclusions:

• The developed chimeric regulatory strategy overcomes limitations of single-element systems for integrated glioma theranostics.
• This system shows significant potential for enhancing MRI-based glioblastoma detection and targeted therapy.
• The modular design is potentially adaptable to other reporter genes and malignancies.